XMXuSheng Ma

XuSheng Ma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


XuSheng Ma has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Haixue Zheng

    State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences

    3 shared publications
  • Sk Mohiuddin Choudhury

    Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA

    2 shared publications
  • Ao Dong

    Yunnan University

    1 shared publication
  • Chuangfu Chen

    College of Animal Science and Technology, Shihezi University, Shihezi, 832000, China.

    1 shared publication
  • Fagang Zhong

    State Key Laboratory of Sheep Genetic Improvement and Healthy Production/Xinjiang Academy of Agricultural and Reclamation Sciences, Shihezi, Xinjiang 832000, CHINA

    1 shared publication
  • Fan Lai

    State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, Center for Life Science, Yunnan Key Labora-tory of Cell Metabolism and Diseases,School of Life Sciences, Yunn

    1 shared publication

Latest Publications

  • Open Access

    Orally Available Small Molecule Regulates TXNIP Expression and Glucagon Action for the Treatment of Diabetes

    by Xiaolei Wang, Zhikuan Luo, Jun Han, Qiong Tian, Ruijun Jing, Ao Dong, Lingzhi Li, Hongbin Jia, Tinghong Lv, Yunkun Dang, et al.

    In the progression of diabetes, sustained glucagon secretion facilitates glucose production. Despite its significance, no treatments currently target this vital parameter. We employed the promoter sequence of thioredoxin-interacting protein (TXNIP) as a screening target, evaluated our in-house chemical library, and subsequently undertook high-throughput screening and optimization via various medicinal chemistry techniques. Our efforts led to the identification of SKL-1223, an orally administered, non-toxic small molecule capable of effectively regulating blood glucose levels in both streptozotocin-induced and obesity-induced (db/db) diabetic mice. Furthermore, our study elucidated the hypoglycemic effect of glucagon and its role in reducing hepatic glucose output. On a mechanistic level, SKL-1223 interacts with the E-box region of the TXNIP promoter, consequently suppressing TXNIP transcription and associated signaling pathways. Thus, our study introduces a novel compound, offering a fresh therapeutic avenue for diabetes beyond existing regimens.

  • Open Access

    FMDV 3A Antagonizes the Effect of ANXA1 to Positively Modulate Viral Replication

    by XuSheng Ma, KeShan Zhang, ZhiKuan Luo, XiaoFeng Nian, S. K. Mohiuddin Choudhury, ZiXiang Zhu, Rui Song, JingJing Pei, YanLi Huo, YuanYuan Li, et al.

    FMDV is a pathogen that causes one of the world’s most destructive and highly contagious animal diseases. The FMDV 3A protein plays a critical role in viral replication and host range.


  • Open Access

    Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses

    by Sk Mohiuddin Choudhury, XuSheng Ma, Sahibzada Waheed Abdullah, HaiXue Zheng

    Inflammation refers to the response of the immune system to viral, bacterial, and fungal infections, or other foreign particles in the body, which can involve the production of a wide array of soluble inflammatory mediators. It is important for the development of many RNA virus-infected diseases. The primary factors through which the infection becomes inflammation involve inflammasome. Inflammasomes are proteins complex that the activation is responsive to specific pathogens, host cell damage, and other environmental stimuli. Inflammasomes bring about the maturation of various pro-inflammatory cytokines such as IL-18 and IL-1β in order to mediate the innate immune defense mechanisms. Many RNA viruses and their components, such as encephalomyocarditis virus (EMCV) 2B viroporin, the viral RNA of hepatitis C virus, the influenza virus M2 viroporin, the respiratory syncytial virus (RSV) small hydrophobic (SH) viroporin, and the human rhinovirus (HRV) 2B viroporin can activate the Nod-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) inflammasome to influence the inflammatory response. On the other hand, several viruses use virus-encoded proteins to suppress inflammation activation, such as the influenza virus NS1 protein and the measles virus (MV) V protein. In this review, we summarize how RNA virus infection leads to the activation or inhibition of the NLRP3 inflammasome.


  • Open Access

    Çin’de BVDV 1q’nun Tespiti: Patojenitesinin Araştırılması Amacıyla Genetik Karakterizasyon ve Deneysel Enfeksiyon

    by Yanhua He, Xusheng Ma, Xin Huang, Jinliang Sheng, Fagang Zhong, Xinxia Zhao, Yunfen Zhang, Chuangfu Chen